Trials / Conditions / HER2 Expression
HER2 Expression
4 registered clinical trials studyying HER2 Expression — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Whole Body HER2 Quantification With 89Zr-Trastuzumab PET/CT to Asses Zr-trastuzumab Accumulation in HER2-mutat NCT07436858 | The Netherlands Cancer Institute | Phase 1 |
| Unknown | HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China NCT06238284 | Chongqing University Cancer Hospital | — |
| Unknown | RC48 Combined With Toripalimab and Radiotherapy for Bladder Sparing Treatment in MIBC NCT05979740 | RenJi Hospital | Phase 2 |
| Unknown | Paclitaxel-trastuzumab in EGFR-mutated NSCLC Patients NCT02226757 | Amsterdam UMC, location VUmc | Phase 2 |